APA (7th ed.) Citation

Y, C., X, Z., M, O., KR, S., A, S., J, G., . . . TK, K. (2026). Streamlined resource-efficient plasma amyloid-beta mass spectrometry assay has improved biomarker performance in preclinical Alzheimer's disease. Nature communications, 17(1), 1673. https://doi.org/10.1038/s41467-026-68372-w

Chicago Style (17th ed.) Citation

Y, Chen, et al. "Streamlined Resource-efficient Plasma Amyloid-beta Mass Spectrometry Assay Has Improved Biomarker Performance in Preclinical Alzheimer's Disease." Nature Communications 17, no. 1 (2026): 1673. https://doi.org/10.1038/s41467-026-68372-w.

MLA (9th ed.) Citation

Y, Chen, et al. "Streamlined Resource-efficient Plasma Amyloid-beta Mass Spectrometry Assay Has Improved Biomarker Performance in Preclinical Alzheimer's Disease." Nature Communications, vol. 17, no. 1, 2026, p. 1673, https://doi.org/10.1038/s41467-026-68372-w.